Zhejiang Medicine Co Ltd (600216) — Financial Flexibility Index
Zhejiang Medicine Co Ltd (600216) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥770.79 Million (operating CF CN¥690.77 Million minus capex CN¥80.03 Million) represents 0% of total liabilities (CN¥2.92 Billion). Check 600216 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Medicine Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Zhejiang Medicine Co Ltd across 28 annual periods. See Zhejiang Medicine Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Medicine Co Ltd. For the full company profile including market capitalisation, see Zhejiang Medicine Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥2.33 Billion | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +18.9% |
| 2024 | 0.65x | CN¥1.91 Billion | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +27.5% |
| 2023 | 0.51x | CN¥1.43 Billion | CN¥634.31 Million | CN¥2.79 Billion | ▼ -6.8% |
| 2022 | 0.55x | CN¥1.50 Billion | CN¥520.60 Million | CN¥2.72 Billion | ▼ -11.3% |
| 2021 | 0.62x | CN¥2.08 Billion | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -14.6% |
| 2020 | 0.73x | CN¥1.79 Billion | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +49.9% |
| 2019 | 0.48x | CN¥1.02 Billion | CN¥447.25 Million | CN¥2.11 Billion | ▼ -6.8% |
| 2018 | 0.52x | CN¥1.02 Billion | CN¥579.91 Million | CN¥1.96 Billion | ▼ -2.6% |
| 2017 | 0.53x | CN¥1.07 Billion | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.3% |
| 2016 | 0.39x | CN¥717.90 Million | CN¥336.14 Million | CN¥1.82 Billion | ▼ -22.6% |
| 2015 | 0.51x | CN¥831.50 Million | CN¥106.54 Million | CN¥1.63 Billion | ▼ -56.8% |
| 2014 | 1.18x | CN¥1.54 Billion | CN¥549.90 Million | CN¥1.31 Billion | ▼ -31.2% |
| 2013 | 1.71x | CN¥1.84 Billion | CN¥655.09 Million | CN¥1.08 Billion | ▼ -15.9% |
| 2012 | 2.04x | CN¥1.75 Billion | CN¥807.49 Million | CN¥860.73 Million | ▲ +29.4% |
| 2011 | 1.57x | CN¥1.26 Billion | CN¥912.75 Million | CN¥798.63 Million | ▼ -16.7% |
| 2010 | 1.89x | CN¥1.46 Billion | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.9% |
| 2009 | 1.59x | CN¥1.62 Billion | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +73.4% |
| 2008 | 0.92x | CN¥1.33 Billion | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +373.9% |
| 2007 | 0.19x | CN¥381.05 Million | CN¥227.67 Million | CN¥1.97 Billion | ▼ -19.3% |
| 2006 | 0.24x | CN¥419.49 Million | CN¥169.51 Million | CN¥1.75 Billion | ▼ -3.7% |
| 2005 | 0.25x | CN¥367.08 Million | CN¥25.14 Million | CN¥1.48 Billion | ▲ +17.6% |
| 2004 | 0.21x | CN¥252.40 Million | CN¥107.60 Million | CN¥1.19 Billion | ▲ +11.4% |
| 2003 | 0.19x | CN¥197.57 Million | CN¥66.20 Million | CN¥1.04 Billion | ▼ -19.3% |
| 2002 | 0.24x | CN¥236.94 Million | CN¥23.13 Million | CN¥1.01 Billion | ▲ +2.9% |
| 2001 | 0.23x | CN¥218.69 Million | CN¥98.25 Million | CN¥956.66 Million | ▲ +36.5% |
| 2000 | 0.17x | CN¥134.28 Million | CN¥10.58 Million | CN¥801.61 Million | ▲ +419.4% |
| 1999 | 0.03x | CN¥35.32 Million | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -86.3% |
| 1998 | 0.23x | CN¥183.80 Million | CN¥57.72 Million | CN¥782.87 Million | — |